Literature DB >> 21274726

Common genetic variation in the 3'-untranslated region of gonadotropin-releasing hormone receptor regulates gene expression in cella and is associated with thyroid function, insulin secretion as well as insulin sensitivity in polycystic ovary syndrome patients.

Qiaoli Li1, Guizhong Yang, Ying Wang, Xiaoping Zhang, Qing Sang, Huan Wang, Xinzhi Zhao, Qinghe Xing, Lin He, Lei Wang.   

Abstract

Gonadotropin-releasing hormone receptor (GNRHR) is a member of the G protein-coupled Ca(2+)-dependent family of receptors. It interacts with GnRH, whose signaling plays an important role in thyroid-stimulating hormone (TSH) secretion and insulin activity. There has been no study on the genetic effect of GNRHR on TSH secretion and insulin action in polycystic ovary syndrome (PCOS). We decided to investigate whether naturally occurring genetic variation at the human GNRHR locus is associated with thyroid function, insulin secretion and insulin sensitivity in PCOS. We undertook a systematic search for polymorphisms in GNRHR by resequencing the gene and then genotyped common single-nucleotide polymorphisms across the locus in 261 PCOS patients well-phenotyped for several metabolic traits to determine associations. A test for association of common genetic variants with susceptibility to PCOS was carried out in a large cohort of 948 subjects. Finally, we experimentally validated the marker-on-trait associations using GNRHR 3'-UTR region/reporter analysis in 293T cells. The 3'-UTR variant rs1038426 was associated with serum thyroid concentration (P = 0.007), change of insulin levels during oral glucose tolerance test (P = 0.004) and insulin sensitivity index (P = 0.014). In a functional study, 3'-UTR variant T allele increased reporter expression by a transfected luciferase reporter/GNRHR 3'-UTR expression plasmid. In conclusion, our results strongly suggest that common genetic variant in GNRHR contributes to the phenotypic expression of PCOS. The findings suggest novel pathophysiological links between the GNRHR locus and thyroid function and insulin secretion in PCOS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21274726     DOI: 10.1007/s00439-011-0954-4

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  28 in total

1.  Insulin sensitivity during combined androgen blockade for prostate cancer.

Authors:  Matthew R Smith; Hang Lee; David M Nathan
Journal:  J Clin Endocrinol Metab       Date:  2006-01-24       Impact factor: 5.958

2.  A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

Authors:  E Diamanti-Kandarakis; C R Kouli; A T Bergiele; F A Filandra; T C Tsianateli; G G Spina; E D Zapanti; M I Bartzis
Journal:  J Clin Endocrinol Metab       Date:  1999-11       Impact factor: 5.958

Review 3.  Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.

Authors:  A Dunaif
Journal:  Endocr Rev       Date:  1997-12       Impact factor: 19.871

Review 4.  Molecular mechanisms of insulin resistance in polycystic ovary syndrome.

Authors:  Evanthia Diamanti-Kandarakis; Athanasios G Papavassiliou
Journal:  Trends Mol Med       Date:  2006-07       Impact factor: 11.951

5.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

6.  Interactions among thyroid function, insulin sensitivity, and serum lipid concentrations: the Fremantle diabetes study.

Authors:  S A P Chubb; W A Davis; T M E Davis
Journal:  J Clin Endocrinol Metab       Date:  2005-06-28       Impact factor: 5.958

7.  Thyroid function in humans with morbid obesity.

Authors:  Marina A Michalaki; Apostolos G Vagenakis; Aggeliki S Leonardou; Marianna N Argentou; Ioannis G Habeos; Maria G Makri; Agathoklis I Psyrogiannis; Fotis E Kalfarentzos; Venetsana E Kyriazopoulou
Journal:  Thyroid       Date:  2006-01       Impact factor: 6.568

8.  Insulin augments gonadotropin-releasing hormone induction of translation in LbetaT2 cells.

Authors:  Amy M Navratil; Hyunjin Song; Jeniffer B Hernandez; Brian D Cherrington; Sharon J Santos; Janine M Low; Minh-Ha T Do; Mark A Lawson
Journal:  Mol Cell Endocrinol       Date:  2009-07-24       Impact factor: 4.102

9.  Pleiotropic effects of novel trans-acting loci influencing human sympathochromaffin secretion.

Authors:  Tiffany A Greenwood; Fangwen Rao; Mats Stridsberg; Nitish R Mahapatra; Manjula Mahata; Elizabeth O Lillie; Sushil K Mahata; Laurent Taupenot; Nicholas J Schork; Daniel T O'Connor
Journal:  Physiol Genomics       Date:  2006-03-22       Impact factor: 3.107

10.  Development of radioimmunoassay for bullfrog thyroid-stimulating hormone (TSH): effects of hypothalamic releasing hormones on the release of TSH from the pituitary in vitro.

Authors:  Reiko Okada; Kazutoshi Yamamoto; Aya Koda; Yoichi Ito; Hiroaki Hayashi; Shigeyasu Tanaka; Yoichi Hanaoka; Sakaé Kikuyama
Journal:  Gen Comp Endocrinol       Date:  2004-01-01       Impact factor: 2.822

View more
  8 in total

1.  Genome-wide meta-analysis identifies novel loci associated with free triiodothyronine and thyroid-stimulating hormone.

Authors:  M Popović; A Matana; V Torlak; T Boutin; D Brdar; I Gunjača; D Kaličanin; I Kolčić; V Boraska Perica; A Punda; O Polašek; M Barbalić; C Hayward; T Zemunik
Journal:  J Endocrinol Invest       Date:  2019-03-07       Impact factor: 4.256

Review 2.  Thyroid hormone's role in regulating brain glucose metabolism and potentially modulating hippocampal cognitive processes.

Authors:  V Jahagirdar; E C McNay
Journal:  Metab Brain Dis       Date:  2012-03-23       Impact factor: 3.584

3.  Common genetic variation in CYP1B1 is associated with concentrations of T₄, FT₃ and FT₄ in the sera of polycystic ovary syndrome patients.

Authors:  Shien Zou; Qing Sang; Huan Wang; Ruizhi Feng; Qiaoli Li; Xinzhi Zhao; Qinghe Xing; Li Jin; Lin He; Lei Wang
Journal:  Mol Biol Rep       Date:  2013-01-03       Impact factor: 2.316

4.  Polycystic ovary syndrome: clinical presentation in normal-weight compared with overweight adolescents.

Authors:  Shilpa S McManus; Lynne L Levitsky; Madhusmita Misra
Journal:  Endocr Pract       Date:  2013 May-Jun       Impact factor: 3.443

5.  The relationship between thyroiditis and polycystic ovary syndrome: a meta-analysis.

Authors:  Danfeng Du; Xuelian Li
Journal:  Int J Clin Exp Med       Date:  2013-10-25

Review 6.  Pathophysiological mechanisms of gonadotropins- and steroid hormones-related genes in etiology of polycystic ovary syndrome.

Authors:  Zahra Shaaban; Arezoo Khoradmehr; Mohammad Reza Jafarzadeh Shirazi; Amin Tamadon
Journal:  Iran J Basic Med Sci       Date:  2019-01       Impact factor: 2.699

Review 7.  Genetic Susceptibility to Joint Occurrence of Polycystic Ovary Syndrome and Hashimoto's Thyroiditis: How Far Is Our Understanding?

Authors:  Natalia Zeber-Lubecka; Ewa E Hennig
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

8.  Role of Single Nucleotide Variants in FSHR, GNRHR, ESR2 and LHCGR Genes in Adolescents with Polycystic Ovary Syndrome.

Authors:  Lasma Lidaka; Laine Bekere; Adele Rota; Jekaterina Isakova; Gunta Lazdane; Anda Kivite-Urtane; Iveta Dzivite-Krisane; Inga Kempa; Zane Dobele; Linda Gailite
Journal:  Diagnostics (Basel)       Date:  2021-12-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.